The seed round was led by Osney Capital with backing from several venture firms to scale technical teams and product development.
"The AI security industry is trying to secure the wrong thing. Models will always be vulnerable to adversarial inputs – that’s a fundamental property of how they work. But what happens when an agent is live in production, interacting with real systems, and its behaviour starts to drift? Right now, most teams have no idea. Overmind provides the deployment-layer infrastructure needed to monitor agent interactions and intervene before damage occurs."
The pre-seed round was led by Presto Tech Horizons to accelerate front-line drone autonomy deployments.
"Drone pilots are rare resources. Not everyone is a natural pilot and Russia targets them whenever they can find them. Pilots face challenges when operating drones, including electronic warfare, signals loss, and denial of GPS."
The seed round was led by MMC Ventures with participation from Episode 1 Ventures and Seedcamp to fund team expansion and product development.
"The pharmaceutical industry has made tremendous strides in AI for hit identification and lead optimisation, but target safety assessment has lagged behind. Sable is positioned to change that by making comprehensive safety data accessible and actionable. We’re thrilled that with this funding, we can build the definitive platform for drug target safety."
The biotechnology funding pairs strategic capital with a collaborative agreement to explore oncology opportunities.
"This strategic investment is an important endorsement of AMPLY's platform and our approach to oncology. We're building a company designed for partnering – generating high-quality, data-driven programmes and taking them to clear inflection points. We're delighted to welcome Keeps Biomed as a strategic investor, and to bring Oliver on board as CSO to help sharpen our oncology execution and partnering readiness."
